Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ecabet Ophthalmic Solution for Dry Eye Syndrome
NCT00198536Phase 3Completed
- Sponsor
- Bausch + Lomb
- Start
- Apr 2005
- Primary completion
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ecabet sodium in dry eye syndrome (DED), sponsored by Bausch + Lomb. Started Apr 2005; status: completed.
02
Drugs
ecabet sodium
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT00198536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00198536.